| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3193613 | Annals of Allergy, Asthma & Immunology | 2006 | 7 Pages |
Abstract
Montelukast provided significant protection against EIB as soon as 2 hours after a single oral dose, with persistent benefit up to 24 hours.
Related Topics
Health Sciences
Medicine and Dentistry
Dermatology
Authors
David S. MD, Janet MD, George MD, Stephen A. MD, William PharmD, Leslie PhD, Thomas PhD, S.B. PhD, Theodore F. MD,